Insight

Alessandro Santin: This is a major ‘bench-to-bedside’ accomplishment for uterine cancer patients

Photo taken from medicine.yale.edu

Aug 2, 2024, 14:00

Alessandro Santin: This is a major ‘bench-to-bedside’ accomplishment for uterine cancer patients

Yale Cancer Center made the following post on X:

“Led by Dr. Alessandro Santin and researchers at Yale Cancer Center, the TROPiCS-03 phase II study for patients with advanced or recurrent endometrial cancer has advanced to a phase III trial. ‘This is a major ‘bench-to-bedside’ accomplishment for uterine cancer patients,’ said Dr. Santin.”

Read further.
Source: Yale Cancer Center/X

advanced endometrial cancer Alessandro Santin bench-to-bedside cancer cancer treatment advancement clinical trial progress Dr. Alessandro Santin endometrial cancer treatment OncoDaily Oncology oncology research phase II study Phase III trial recurrent endometrial cancer TROPiCS-03 study uterine cancer research Yale Cancer Center

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage